Therapeutic drug monitoring is necessary for patients receiving posaconazole tablet-Reference-Cited by-同舟云学术

Therapeutic drug monitoring is necessary for patients receiving posaconazole tablet

Published:2021-06 Issue:6 Volume:82 Page:e18-e21
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Zhou Peijun Yvonne,Lim Tze Peng,Tang Si Lin Sarah,Lim Jia Le,Liew Yixin,Chua Nathalie Grace,Lim Li Ling Cheryl,Lee Hui Ling Winnie,Lai Oi Fah,Tan Thuan Tong,Wong Gee Chuan,Kwa Lay Hoon Andrea

Funder

National Medical Research Council

Merck Sharp & Dohme Ltd

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline;Ullmann;Clin Microbiol Infect,2018

2. Subtherapeutic posaconazole troughs despite high-dose posaconazole tablets in a patient with terminal ileum resection;Zhou;J Infect,2019

3. Risk factors for subtherapeutic levels of posaconazole tablet;Tang;J Antimicrob Chemother,2017

4. Failure to achieve therapeutic levels with high-dose posaconazole tablets potentially due to enhanced clearance;Maleki;J Oncol Pharm Pract,2018

5. Antifungal prophylaxis with posaconazole delayed-release tablet and oral suspension in a real-life setting: plasma levels, efficacy, and tolerability;Lenczuk;Antimicrob Agents Chemother,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey;Frontiers in Pharmacology;2022-10-10

2. Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients;Leukemia & Lymphoma;2022-09-29